Benjamin Bakall

2.4k total citations · 1 hit paper
33 papers, 1.7k citations indexed

About

Benjamin Bakall is a scholar working on Molecular Biology, Ophthalmology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Benjamin Bakall has authored 33 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 18 papers in Ophthalmology and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Benjamin Bakall's work include Retinal Development and Disorders (20 papers), Retinal Diseases and Treatments (13 papers) and Neuroscience and Neuropharmacology Research (4 papers). Benjamin Bakall is often cited by papers focused on Retinal Development and Disorders (20 papers), Retinal Diseases and Treatments (13 papers) and Neuroscience and Neuropharmacology Research (4 papers). Benjamin Bakall collaborates with scholars based in United States, Sweden and Germany. Benjamin Bakall's co-authors include Claes Wadelius, Alan D. Marmorstein, Sten Andréasson, Edwin M. Stone, Lihua Y. Marmorstein, Neal S. Peachey, Konstantin Petrukhin, Ola Sandgren, Arthur A. Bergen and Wen Li and has published in prestigious journals such as Nature Genetics, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Benjamin Bakall

32 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of the gene responsible for Best macular dystrophy

1998 541 citations Konstantin Petrukhin, Benjamin Bakall et al. Nature Genetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Benjamin Bakall United States	16	1.4k	943	360	345	211	33	1.7k
Genevieve Wright United Kingdom	18	1.2k 0.9×	822 0.9×	214 0.6×	215 0.6×	188 0.9×	35	1.4k
Markus N. Preising Germany	25	1.5k 1.1×	1.2k 1.3×	210 0.6×	383 1.1×	264 1.3×	77	1.8k
Luan M. Streb United States	14	1.5k 1.1×	1.0k 1.1×	245 0.7×	429 1.2×	212 1.0×	23	2.1k
Abigail T. Fahim United States	18	780 0.6×	504 0.5×	284 0.8×	225 0.7×	207 1.0×	43	1.1k
Nicole Weisschuh Germany	27	1.3k 1.0×	964 1.0×	124 0.3×	270 0.8×	251 1.2×	73	1.8k
Alice E. Davidson United Kingdom	26	1.3k 0.9×	987 1.0×	187 0.5×	741 2.1×	203 1.0×	54	2.0k
Alan Lennon United Kingdom	13	1.2k 0.9×	550 0.6×	156 0.4×	151 0.4×	250 1.2×	17	1.4k
C.F. Inglehearn United Kingdom	19	1.2k 0.8×	410 0.4×	363 1.0×	142 0.4×	216 1.0×	34	1.3k
Fiona C. Mansergh Ireland	19	770 0.6×	393 0.4×	260 0.7×	157 0.5×	214 1.0×	36	1.2k
Bernhard Jurklies Germany	21	1.8k 1.3×	1.6k 1.7×	253 0.7×	608 1.8×	276 1.3×	49	2.6k

Countries citing papers authored by Benjamin Bakall

Since Specialization

Citations

This map shows the geographic impact of Benjamin Bakall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Bakall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Bakall more than expected).

Fields of papers citing papers by Benjamin Bakall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Bakall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Bakall. The network helps show where Benjamin Bakall may publish in the future.

Co-authorship network of co-authors of Benjamin Bakall

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Bakall. A scholar is included among the top collaborators of Benjamin Bakall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Bakall. Benjamin Bakall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bakall, Benjamin, et al.. (2026). A novel modifier gene therapy to treat Stargardt disease: Phase 1 GARDian1 Trial Insights. Eye. 40(3). 429–430.

Bommakanti, Nikhil, Benjamin K. Young, Robert A. Sisk, et al.. (2023). Classification and Growth Rate of Chorioretinal Atrophy after Voretigene Neparvovec-Rzyl for RPE65-Mediated Retinal Degeneration. Ophthalmology Retina. 8(1). 42–48. 20 indexed citations

Khanani, Arshad M., Raj K. Maturi, Nika Bagheri, et al.. (2022). A Phase I, Single Ascending Dose Study of GEM103 (Recombinant Human Complement Factor H) in Patients with Geographic Atrophy. SHILAP Revista de lepidopterología. 2(2). 100154–100154. 15 indexed citations

Issa, Reda, et al.. (2020). Retinal Manifestations of Incontinentia Pigmenti: A Case Series of 14 Patients Highlighting the Importance of Intravenous Fluorescein Angiography and the Benefits of Early Laser Photocoagulation. Journal of VitreoRetinal Diseases. 5(1). 60–65. 1 indexed citations

Chan, Jane W., Nancy K. Hills, Benjamin Bakall, & Brian Fernández. (2019). Indirect Traumatic Optic Neuropathy in Mild Chronic Traumatic Brain Injury. Investigative Ophthalmology & Visual Science. 60(6). 2005–2005. 22 indexed citations

Bakall, Benjamin, et al.. (2018). Extensive Grouped Congenital Hypertrophy of the Retinal Pigment Epithelium. Ophthalmology Retina. 2(3). 224–224. 1 indexed citations

Khan, Kamron N., Mohammed E. El‐Asrag, Cristy A. Ku, et al.. (2017). Specific Alleles of CLN7 / MFSD8 , a Protein That Localizes to Photoreceptor Synaptic Terminals, Cause a Spectrum of Nonsyndromic Retinal Dystrophy. Investigative Ophthalmology & Visual Science. 58(7). 2906–2906. 38 indexed citations

Mahajan, Vinit B., David R.P. Almeida, Eric K. Chin, et al.. (2016). Comparison of microbiology and visual outcomes of patients undergoing small-gauge and 20-gauge vitrectomy for endophthalmitis. Clinical ophthalmology. 10. 167–167. 7 indexed citations

Bakall, Benjamin, et al.. (2014). Novel mutations and change of nomenclature for pathogenic variants in the TIMP3 gene causing Sorsby fundus dystrophy. Investigative Ophthalmology & Visual Science. 55(13). 3290–3290. 4 indexed citations

10.

Bakall, Benjamin, James C. Folk, H. Culver Boldt, et al.. (2013). Aflibercept Therapy for Exudative Age-related Macular Degeneration Resistant to Bevacizumab and Ranibizumab. American Journal of Ophthalmology. 156(1). 15–22.e1. 190 indexed citations

11.

Braun, Terry A., Robert F. Mullins, Alex H. Wagner, et al.. (2013). Non-exomic and synonymous variants in ABCA4 are an important cause of Stargardt disease. Human Molecular Genetics. 22(25). 5136–5145. 139 indexed citations

12.

Xu, Xiayu, Joseph M. Reinhardt, Benjamin Bakall, et al.. (2012). Retinal Vessel Width Measurement at Branchings Using an Improved Electric Field Theory-Based Graph Approach. PLoS ONE. 7(11). e49668–e49668. 5 indexed citations

13.

Bakall, Benjamin, P. J. McLaughlin, J. Brett Stanton, et al.. (2007). The Bestrophin-2 Knock-Out Mouse: Histological and Functional Analysis. Investigative Ophthalmology & Visual Science. 48(13). 2983–2983. 1 indexed citations

14.

McLaughlin, Precious J., Benjamin Bakall, Ji-Won Choi, et al.. (2007). Lack of fibulin-3 causes early aging and herniation, but not macular degeneration in mice. Human Molecular Genetics. 16(24). 3059–3070. 118 indexed citations

15.

Bakall, Benjamin, Roxana A. Radu, J. Brett Stanton, et al.. (2007). Enhanced accumulation of A2E in individuals homozygous or heterozygous for mutations in BEST1 (VMD2). Experimental Eye Research. 85(1). 34–43. 77 indexed citations

16.

Strauß, Olaf, Alan D. Marmorstein, Lihua Y. Marmorstein, et al.. (2004). Bestrophin modulates activity of L–type Ca2+ channels in RPE cells. Investigative Ophthalmology & Visual Science. 45(13). 1760–1760. 2 indexed citations

17.

Eksandh, Louise, Benjamin Bakall, Birgitta Bauer, Claes Wadelius, & Sten Andréasson. (2001). Best’s vitelliform macular dystrophy caused by a new mutation (Val89Ala) in the VMD2 gene. Ophthalmic Genetics. 22(2). 107–115. 30 indexed citations

18.

Ponjavic, Vesna, Louise Eksandh, Sten Andréasson, et al.. (1999). Clinical expression of Best's vitelliform macular dystrophy in Swedish families with mutations in the bestrophin gene. Ophthalmic Genetics. 20(4). 251–257. 36 indexed citations

19.

Petrukhin, Konstantin, Benjamin Bakall, Wen Li, et al.. (1998). Identification of the gene responsible for Best macular dystrophy. Nature Genetics. 19(3). 241–247. 541 indexed citations breakdown →

20.

Melberg, Atle, Henrik Arnell, Niklas Dahl, et al.. (1996). Anticipation of autosomal dominant progressive external ophthalmoplegia with hypogonadism. Muscle & Nerve. 19(12). 1561–1569. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact